NIPER and Roche Pharma Boost Education and Research in India
NEW DELHI, India, March 17, 2026 The National Institute of Pharmaceutical Education and Research (NIPER) Raebareli has signed a...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
NEW DELHI, India, March 17, 2026 The National Institute of Pharmaceutical Education and Research (NIPER) Raebareli has signed a...
Florence, Italy – March 9, 2026 Menarini Group, one of Europe’s leading pharmaceutical companies, has reported strong financial growth...
March 06, 2026 — Cambridge, Massachusetts, USA A significant milestone has been reached in AI-driven pharmaceutical development as Insilico...
March 08, 2026 — Cambridge, MA, USA The rapid integration of artificial intelligence in pharmaceutical research continues to reshape...
